MedTrace Logo

Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.

NCT03305978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-08-21

No results posted yet for this study

Summary

Lung cancer screening programs are still discussed in Europe today, and one of the concern is radiation due to iterative CT. The aim of this monocentric, prospective, non randomized study is to compare an ultra low dose chest CT (approaching a two views X ray) versus a standard low dose chest CT for ≥4mm lung nodules detection, and secondary for lung nodule characterization and smoking associated findings (emphysema, bronchial abnormalities and coronary calcifications).

Conditions

Interventions

DEVICE

Ultra low dose chest CT

An additional ultra low dose CT row is performed for every subject besides standard diagnostic low dose chest CT.

DEVICE

Low dose chest CT

standard diagnostic low dose chest CT

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Gilbert Ferretti, MD, PhD · University Hospital, Grenoble

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-26
Primary Completion
2019-07-10
Completion
2019-07-10

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03305978 on ClinicalTrials.gov